Furthermore, both self- (licensed) and non-self (un-licensed) CIML NK cells have similar anti-tumor responses, suggesting that the traditional KIR/KIR-ligand mismatch may not fully apply to these cells [59]. This evidence concerns the gene KIR3DL1 and neoplasm.